KEMTA masterclass: Using early Health Technology Assessment (HTA) to estimate the cost-effectiveness and support strategic decisions for innovative technologies
Masterclass
Using early Health Technology Assessment (HTA) to estimate the cost-effectiveness and support strategic decisions for innovative technologies
By: Sabine Grimm/Bram Ramaekers
Language: English
The masterclasses will take place via Teams of Zoom. You can register by sending an e-mail to: Irene.vrancken@mumc.nl.
KEMTA (Clinical Epidemiology & Medical Technology Assessment) of MUMC+ regularly organises masterclasses for employees interested in research methods. The masterclasses give short insights into a variety of topics, from the basics of setting up research to statistics and hot topics such as early HTA.
Also read
-
23 Sep10:00
PhD Defence Nivine Hanach
"Postpartum Depression in the UAE: Insights, Challenges, and Pathways to Support"
-
23 Sep13:00
PhD Defence Francesco Schianchi
"From v-ATPase to protein palmitoylation: Novel targets against lipid-induced cardiomyopathy"
-
23 Sep16:00
PhD Defence Khava Im Elievna Ibragimova
"Real-world treatment patterns and outcomes of patients with HER2+ advanced breast cancer"